I am a highly motivated and versatile professional with over 5 years of experience in pharmacovigilance, clinical research, and regulatory affairs. My expertise spans multiple aspects of the drug development lifecycle, from early-stage clinical trials to post-marketing surveillance and regulatory submissions. I specialize in pharmacovigilance analysis, ensuring the safety of pharmaceutical products by identifying and assessing adverse drug reactions (ADRs), and providing comprehensive case reports. My work is driven by a commitment to maintaining the highest standards of safety, compliance, and quality. Additionally, I bring significant experience in scientific and medical writing, where I have authored and reviewed critical regulatory documents, including Biologics License Applications (BLA), Investigational New Drug (IND) submissions, and eCTD filings, ensuring compliance with global regulatory standards (FDA, EMA, PMDA). I’m also proficient in creating technical writing templates and working cross-functionally with teams to align regulatory strategies and streamline submission processes. I’m passionate about contributing to the success of pharmaceutical and biopharma organizations through clear, compliant, and high-quality documentation that supports every stage of drug development—from discovery to commercialization. I thrive in dynamic, fast-paced environments and am constantly looking for ways to improve processes, enhance team collaboration, and drive successful regulatory outcomes.